The role of lymph node dissection in the surgical treatment of endometrial cancer patients (retrospective analysis)
- PMID: 36219260
- PMCID: PMC11796981
- DOI: 10.1007/s00432-022-04406-2
The role of lymph node dissection in the surgical treatment of endometrial cancer patients (retrospective analysis)
Retraction in
-
Retraction Note: The role of lymph node dissection in the surgical treatment of endometrial cancer patients (retrospective analysis).J Cancer Res Clin Oncol. 2024 Mar 22;150(3):151. doi: 10.1007/s00432-024-05690-w. J Cancer Res Clin Oncol. 2024. PMID: 38517558 Free PMC article. No abstract available.
Abstract
Purpose: Endometrial cancer in recent years has taken the lead among cancer processes of the female reproductive system. The feasibility of pelvic and para-aortic lymph node dissection in patients with endometrial cancer has always been a controversial issue. The aim of the presented paper is to evaluate the feasibility of pelvic and para-aortic lymph node dissection in patients with endometrial cancer, depending on the stage of the disease, postoperative complications, and patient survival, depending on the volume of surgical intervention.
Methods: The study involved 285 patients with stages of I-IV endometrioid endometrial cancer of the Pre-graduate Department of Oncogynecology of the National Cancer Institute. The average age of patients was 55 ± 5.7 years. In 74.5%, the disease was detected at stage I and uterine extirpation was performed with/without appendages.
Results: The duration of the operation varies depending on the volume of intervention-from 1 h 30 min ± 10 min for panhysterectomy, up to 3 h 20 min ± 10 min when performing para-aortic lymph node dissection. The average number of lymph nodes removed was-7 ± 1.1 pelvic and 12 ± 1.5 para-aortic.
Conclusion: The basic principles of surgical treatment consist in individual choice of the scope of surgical intervention, performing adequate lymph node dissection, and preventing relapse and metastasis of the disease.
Keywords: Endometrial cancer; Laparoscopy; Laparotomy; Pelvic lymph node dissection; Surgery.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare no conflict of interests.
Figures


Similar articles
-
Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer.Cochrane Database Syst Rev. 2025 Jun 10;6(6):CD015786. doi: 10.1002/14651858.CD015786.pub2. Cochrane Database Syst Rev. 2025. PMID: 40492478 Review.
-
Influence of Prognostic Factors on Lymph Node Involvement in Endometrial Cancer: A Single-Center Experience.Int J Gynecol Cancer. 2018 Jul;28(6):1145-1152. doi: 10.1097/IGC.0000000000001290. Int J Gynecol Cancer. 2018. PMID: 29757871
-
Lymphadenectomy for the management of endometrial cancer.Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD007585. doi: 10.1002/14651858.CD007585.pub4. Cochrane Database Syst Rev. 2017. PMID: 28968482 Free PMC article.
-
Lymphadenectomy for the management of endometrial cancer.Cochrane Database Syst Rev. 2015 Sep 21;2015(9):CD007585. doi: 10.1002/14651858.CD007585.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Oct 02;10:CD007585. doi: 10.1002/14651858.CD007585.pub4. PMID: 26387863 Free PMC article. Updated.
-
Therapeutic role of para-aortic lymphadenectomy in patients with intermediate- and high-risk endometrial cancer: a systematic review and meta-analysis.Int J Gynecol Cancer. 2024 Apr 1;34(4):519-527. doi: 10.1136/ijgc-2023-005134. Int J Gynecol Cancer. 2024. PMID: 38296516
Cited by
-
Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database.Front Surg. 2023 Jan 6;9:1001791. doi: 10.3389/fsurg.2022.1001791. eCollection 2022. Front Surg. 2023. PMID: 36684133 Free PMC article. Review.
References
-
- American College of Obstetricians and Gynecologists (2018) ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2018: Management of endometrial cancer. Obstet Gynecol 106(2):413–425. 10.1097/00006250-200508000-00050 - PubMed
-
- Amanta F, Mirzab M, Creutzbergc C (2018) FIGO cancer report 2015. Cancer of the corpus uteri. Intern J of Gynec Obst 143(2):37–50
-
- American Joint Committee on Cancer. Corpus Uteri-Carcinoma and Carcinosarcoma (2017). 10.3322/caac.21388
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources